Strategic biomonitoring initiatives

Moving the science forward

Jürgen Angerer, Michael G. Bird, Thomas Burke, Nancy G. Doerrer, Larry Needham, Steven H. Robison, Linda Sheldon, Hal Zenick

Research output: Contribution to journalArticle

Abstract

Biomonitoring programs in the United States and Europe demonstrate the vast array of data that are publicly available for the evaluation of exposure trends, identification of susceptible populations, detection of emerging chemical risks, the conduct of epidemiology studies, and evaluation of risk reduction strategies. To cultivate international discussion on these issues, the ILSI Health and Environmental Sciences Institute convened a scientific session at its annual meeting in January 2006 on "Integration of Biomonitoring Exposure Data into the Risk Assessment Process." This Forum paper presents perspectives from session speakers on the biomonitoring activities of the Centers for Disease Control and Prevention, the U.S. Environmental Protection Agency, the National Research Council Committee on Human Biomonitoring for Environmental Toxicants, the German Commission on Human Biomonitoring, and the Health and Environmental Sciences Institute Biomonitoring Technical Committee. Speakers noted that better estimates of biological concentrations of substances in the tissues of human populations can be combined with other exposure indices, as well as epidemiological and toxicologic data, to improve risk estimates. With this type of combined data, the potential also exists to define exposure levels at which hazard and risk are of minimal concern. Limitations in interpreting biomonitoring data were discussed, including the need for different criteria for applying biomonitoring data for exposure assessment, risk assessment, risk management, or disease prevention purposes. As efforts and resources are expended to improve the ability to apply biomonitoring exposure data in the risk assessment process, it is equally important to communicate the significance of such data to the public.

Original languageEnglish (US)
Pages (from-to)3-10
Number of pages8
JournalToxicological Sciences
Volume93
Issue number1
DOIs
StatePublished - Sep 15 2006

Fingerprint

Environmental Monitoring
Risk assessment
Health
Disease control
Epidemiology
Environmental Protection Agency
Environmental Health
Risk management
Hazards
Tissue
United States Environmental Protection Agency
Aptitude
Risk Management
Risk Reduction Behavior
Centers for Disease Control and Prevention (U.S.)
Population

Keywords

  • Risk assessment
  • Risk assessment - Biomonitoring
  • Risk assessment - Exposure assessment

ASJC Scopus subject areas

  • Toxicology

Cite this

Angerer, J., Bird, M. G., Burke, T., Doerrer, N. G., Needham, L., Robison, S. H., ... Zenick, H. (2006). Strategic biomonitoring initiatives: Moving the science forward. Toxicological Sciences, 93(1), 3-10. https://doi.org/10.1093/toxsci/kfl042

Strategic biomonitoring initiatives : Moving the science forward. / Angerer, Jürgen; Bird, Michael G.; Burke, Thomas; Doerrer, Nancy G.; Needham, Larry; Robison, Steven H.; Sheldon, Linda; Zenick, Hal.

In: Toxicological Sciences, Vol. 93, No. 1, 15.09.2006, p. 3-10.

Research output: Contribution to journalArticle

Angerer, J, Bird, MG, Burke, T, Doerrer, NG, Needham, L, Robison, SH, Sheldon, L & Zenick, H 2006, 'Strategic biomonitoring initiatives: Moving the science forward', Toxicological Sciences, vol. 93, no. 1, pp. 3-10. https://doi.org/10.1093/toxsci/kfl042
Angerer J, Bird MG, Burke T, Doerrer NG, Needham L, Robison SH et al. Strategic biomonitoring initiatives: Moving the science forward. Toxicological Sciences. 2006 Sep 15;93(1):3-10. https://doi.org/10.1093/toxsci/kfl042
Angerer, Jürgen ; Bird, Michael G. ; Burke, Thomas ; Doerrer, Nancy G. ; Needham, Larry ; Robison, Steven H. ; Sheldon, Linda ; Zenick, Hal. / Strategic biomonitoring initiatives : Moving the science forward. In: Toxicological Sciences. 2006 ; Vol. 93, No. 1. pp. 3-10.
@article{c54a5bbcbbd9436cb43b75695fad7c89,
title = "Strategic biomonitoring initiatives: Moving the science forward",
abstract = "Biomonitoring programs in the United States and Europe demonstrate the vast array of data that are publicly available for the evaluation of exposure trends, identification of susceptible populations, detection of emerging chemical risks, the conduct of epidemiology studies, and evaluation of risk reduction strategies. To cultivate international discussion on these issues, the ILSI Health and Environmental Sciences Institute convened a scientific session at its annual meeting in January 2006 on {"}Integration of Biomonitoring Exposure Data into the Risk Assessment Process.{"} This Forum paper presents perspectives from session speakers on the biomonitoring activities of the Centers for Disease Control and Prevention, the U.S. Environmental Protection Agency, the National Research Council Committee on Human Biomonitoring for Environmental Toxicants, the German Commission on Human Biomonitoring, and the Health and Environmental Sciences Institute Biomonitoring Technical Committee. Speakers noted that better estimates of biological concentrations of substances in the tissues of human populations can be combined with other exposure indices, as well as epidemiological and toxicologic data, to improve risk estimates. With this type of combined data, the potential also exists to define exposure levels at which hazard and risk are of minimal concern. Limitations in interpreting biomonitoring data were discussed, including the need for different criteria for applying biomonitoring data for exposure assessment, risk assessment, risk management, or disease prevention purposes. As efforts and resources are expended to improve the ability to apply biomonitoring exposure data in the risk assessment process, it is equally important to communicate the significance of such data to the public.",
keywords = "Risk assessment, Risk assessment - Biomonitoring, Risk assessment - Exposure assessment",
author = "J{\"u}rgen Angerer and Bird, {Michael G.} and Thomas Burke and Doerrer, {Nancy G.} and Larry Needham and Robison, {Steven H.} and Linda Sheldon and Hal Zenick",
year = "2006",
month = "9",
day = "15",
doi = "10.1093/toxsci/kfl042",
language = "English (US)",
volume = "93",
pages = "3--10",
journal = "Toxicological Sciences",
issn = "1096-6080",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Strategic biomonitoring initiatives

T2 - Moving the science forward

AU - Angerer, Jürgen

AU - Bird, Michael G.

AU - Burke, Thomas

AU - Doerrer, Nancy G.

AU - Needham, Larry

AU - Robison, Steven H.

AU - Sheldon, Linda

AU - Zenick, Hal

PY - 2006/9/15

Y1 - 2006/9/15

N2 - Biomonitoring programs in the United States and Europe demonstrate the vast array of data that are publicly available for the evaluation of exposure trends, identification of susceptible populations, detection of emerging chemical risks, the conduct of epidemiology studies, and evaluation of risk reduction strategies. To cultivate international discussion on these issues, the ILSI Health and Environmental Sciences Institute convened a scientific session at its annual meeting in January 2006 on "Integration of Biomonitoring Exposure Data into the Risk Assessment Process." This Forum paper presents perspectives from session speakers on the biomonitoring activities of the Centers for Disease Control and Prevention, the U.S. Environmental Protection Agency, the National Research Council Committee on Human Biomonitoring for Environmental Toxicants, the German Commission on Human Biomonitoring, and the Health and Environmental Sciences Institute Biomonitoring Technical Committee. Speakers noted that better estimates of biological concentrations of substances in the tissues of human populations can be combined with other exposure indices, as well as epidemiological and toxicologic data, to improve risk estimates. With this type of combined data, the potential also exists to define exposure levels at which hazard and risk are of minimal concern. Limitations in interpreting biomonitoring data were discussed, including the need for different criteria for applying biomonitoring data for exposure assessment, risk assessment, risk management, or disease prevention purposes. As efforts and resources are expended to improve the ability to apply biomonitoring exposure data in the risk assessment process, it is equally important to communicate the significance of such data to the public.

AB - Biomonitoring programs in the United States and Europe demonstrate the vast array of data that are publicly available for the evaluation of exposure trends, identification of susceptible populations, detection of emerging chemical risks, the conduct of epidemiology studies, and evaluation of risk reduction strategies. To cultivate international discussion on these issues, the ILSI Health and Environmental Sciences Institute convened a scientific session at its annual meeting in January 2006 on "Integration of Biomonitoring Exposure Data into the Risk Assessment Process." This Forum paper presents perspectives from session speakers on the biomonitoring activities of the Centers for Disease Control and Prevention, the U.S. Environmental Protection Agency, the National Research Council Committee on Human Biomonitoring for Environmental Toxicants, the German Commission on Human Biomonitoring, and the Health and Environmental Sciences Institute Biomonitoring Technical Committee. Speakers noted that better estimates of biological concentrations of substances in the tissues of human populations can be combined with other exposure indices, as well as epidemiological and toxicologic data, to improve risk estimates. With this type of combined data, the potential also exists to define exposure levels at which hazard and risk are of minimal concern. Limitations in interpreting biomonitoring data were discussed, including the need for different criteria for applying biomonitoring data for exposure assessment, risk assessment, risk management, or disease prevention purposes. As efforts and resources are expended to improve the ability to apply biomonitoring exposure data in the risk assessment process, it is equally important to communicate the significance of such data to the public.

KW - Risk assessment

KW - Risk assessment - Biomonitoring

KW - Risk assessment - Exposure assessment

UR - http://www.scopus.com/inward/record.url?scp=33747882047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747882047&partnerID=8YFLogxK

U2 - 10.1093/toxsci/kfl042

DO - 10.1093/toxsci/kfl042

M3 - Article

VL - 93

SP - 3

EP - 10

JO - Toxicological Sciences

JF - Toxicological Sciences

SN - 1096-6080

IS - 1

ER -